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Patients undergoing coronary angiop 
risk of requiring emergency core 
surgery for impemlii nfarction. 
unique model of early reperfbsion 
died. 
Thirty-six patients were con 
(58%) of 36 bad a radionuclide ventri 
at a mean of 39 f 13 moatks atIer surgery. 
nuclide studies were 
plasty contrast vent 
dial infarction 3 years after surgery. Eleven (55%) of the 
Fatients who have complications of percutaneous translumi- 
nal coronary angioplasty and require urgent coronary artery 
bypass graft surgery serve as a unique human model of early 
reperfusion for impending infarction. Early reperfusion dur- 
ing acute spontaneous myocardial infarction has been ac- 
complished using thrombolytic therapy, coronary bypass 
grafting and coronary angioplasty (I-4). The effect of reper- 
fusion in preventing irreversible myocardial damage has 
been correlated with the presence or absence of coronary 
collateral vessels, the use of medication, the status of the 
coronary microvasculature and the time elapsed between the 
onset of chest pain and institution of therapy (5-8). This 
latter is a confounding variable because symptoms may wax 
and wane and are insensitive indicators of the actual dura- 
tion of ischemia (9,101. In patients who have impending 
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infarction caused by a complication ofcoronary angioplasty, 
however, the time of onset of ischemia is known ith more 
precision because it is angiographically documented. These 
patients are also unique inthat reperfusion isaccomplished 
with cardioplegic solution. 
Recent data suggest that blood reperfusion during infvc- 
tion may result in further myocardial injury, and altering the 
composition of reperfiision solutions may be of benefit 
(1 I-13). The effect of early reperfusion on preservation of
left ventricular function has not been well described in this 
situation. The aim of this study was to assess the late left 
ventricular fttinction i patients undergoing urgent coronary 
bypass graft surgery for ongoing ischemia fter failed coro- 
nary angioplasty. 
The records of all 859 
coronary angioplasty be 
1981 and September 1985 were retrospectively reviewed. 
Patients who were taken directly from the catheterization 
laboratory to the operating room for emergency bypass graft 
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Table 1. Summary of Data on 35 Patients With Failed Coronary 
Angioplasty: Clinical Characteristics of Those With and Without 
Follow-up Radionuclide V ntriculography 
No 
RVG Group RVG Group 
(n = 20) (n = 15) v:ue 
Mean age (yrl 
Gender (M/P) 
Pre PTCA symptoms* 
Class 4 or unstable 
Class 2 or 3 
Class I or asymptomatic 
Pre PEA medications 
Beta-blocker 
Calcium channel blocker 
Nitrates 
Presence of collaterals vessels 
PTCA vessel 
LAD 
RCA 
LCX 
Mean duration of ischemia (min) 
Use of IABP 
Time on bypass (min) 
Mean no. vessels bypassed 
Intraopemtive MI 
Symptoms at follow-up* 
Class 3 or 4 
Class I or asymptomatic 
55 2 6 56 f 4 
1416 1015 
11 (55%) 
9 (45%) 
0 
6 (40%) 
8 (53%) 
I (7%) 
I I (55%) 
13 (65%) 
14 (70%) 
3 (15%) 
8 (53%) 
IO !67%) 
12 (80%) 
3 (20%) 
I2 (60%) 
2 (10%) 
6 (30%) 
147 + 32 
I5 (75%) 
131 r 23 
I.6 2 .7 
4 (20%) 
6 (40%) 
3 (20%) 
6 (40%) 
131 + 23 
9 (60%) 
54 rt 35 
I.5 f .6 
5 (33%) 
I (5%) 
19 (95%) 
1(7%) 
14 (93%) 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
*Canadian Heart Association functional class; F = female; IABP = 
intraaortic balloon pump: LAD = left anterior descending coronary artery; 
LCx = lefl circumflex coronary artery; M = male; Ml = Q wave myocardial 
infarction; PTCA = percutaneous transluminal coronary angioplasty; RCA = 
right coronary artery; RVG = radionuclide ventriculography. 
motion abnormalities, but these findings were unchanged 
from those of the preangioplasty studies (ejection fraction 
50 -r- 5%). 
A significant decrease in ejection fraction from baseline 
study with new wall motioq abnormalities was found in 4 
(20%) of the 20 patients (Fig: I). The mean ejection fraction 
in these four patients decreased from 62 k 18% before 
Figure 1. Late left ventricular function (LVF) in 35 patients. Fol- 
low-up radionuclide v ntriculograms arecompared with preangio- 
plasty contrast ventriculograms. 
NORMAL LVF 
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angioplasty to 37 + 10% at follow-up study. All four 
patients had single vessel coronary artery dise 
angiographic evidence of collateral vessels. Tw 
had dilation ofthe left anterior descending, one 
and one of the left circumflex coronary artery. 
ventricular function was present before angioplasty in three 
of the four patients; two (50%) had complete occlusion and 
two had a patent vessel with decreased blood flow. The 
duration of ischemia could be determined for two f the four 
patients and was 119 and 170 min, respectively. These four 
patients differed significantly from the others only in older 
age (mean age 63 versus 53 years, 
a trend toward higher postoperat 
128 versus 33 ?I 36 NJ/liter), and a 
postoperative Q waves (50% versus 25%) in the gro 
worsened ventricular function, but these differences 
reach statistical significance. 
Many factors have been shown to affect 4e amount of 
myocardial salvage after reperfusion for acute infarction. 
Our study group of patients undergoing eme 
graft surgery after failed angioplasty is unique 
two of these variables can be more accurate 
namely, the duration of ischemia nd the reperfusion solu- 
tion (cardioplegia). 
follow-up radionuclide ventriculography. In addition, com- 
plete coronary occlusion was not demonstrated in all cases, 
and patient variables such as the use of adjuvant medications 
or an intraaortic balloon pump were not controlled. Also, the
study design required comparison ofangiographic and radio- 
nuclide ventriculograms u ing planimetry in the former 
study and a count-based technique to assess left ventricular 
function in the latter. A single view was evaluated forwall 
motion abnormalities and the septum and posterolaterhl 
walls may not have been accurately assessed. Despite these 
limitations, ihis unique group of patients i  more controlled 
than other human models for acute myocardial infarction 
and deserves study. 
Comparison with other studies. We documented un- 
changed left ventricular function at late follow-up study in 
80% of our patients, suggesting significant myocardial sal- 
vage. Our data are consistent with those of others (14-16) in 
that we report a relatively high incidence of myocardial 
infarction with emergency coronary bypass graft surgery 
after coronary angioplasty and a relatively high mortality 
rate. There are few reports on late left ve 
Roberts et al. (17) described a heterogeneous group of 20 
patirnts who underwent emergency bypass graft surgery for 
threatened infarction due to coronary artery catheterization- 
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